Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 18/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15820815 | 1.00 | SLC5A2 (0.54) | SLC5A2 | |
| SCHEMBL22373216 | 0.92 | SLC5A2 (0.48) | SLC5A2 | |
| SCHEMBL20886717 | 0.84 | SLC5A2 (0.43) | SLC5A2 | |
| SCHEMBL12426050 | 0.80 | SLC5A2 (0.67) | SLC5A2 | |
| SCHEMBL8923507 | 0.79 | SLC5A2 (0.48) | SLC5A2 | |
| SCHEMBL9215153 | 0.79 | SLC5A2 (0.48) | SLC5A2 | |
| SCHEMBL15822612 | 0.79 | SLC5A2 (0.63) | SLC5A2 | |
| SCHEMBL15822614 | 0.79 | SLC5A2 (0.63) | SLC5A2 | |
| SCHEMBL8351368 | 0.76 | SLC5A2 (0.73) | SLC5A2 | |
| SCHEMBL15682799 | 0.76 | SLC5A2 (0.73) | SLC5A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160235775-A1 | Mannose Derivatives for Treating Bacterial Infections | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED (CA) | 2016-08-18 | — | — | US | disclosed |
| US-20160235775-A1 | Mannose Derivatives for Treating Bacterial Infections | VERTEX PHARMACEUTICALS (CANADA) INCORPORATED (CA) | 2016-08-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160235775-A1 | Mannose Derivatives for Treating Bacterial Infections | MPI, MANBA, MAN2A1 | SLC5A2 89/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.